Search clinical trials for: Docetaxel injection

Total 11899 results

Sanofi

Completed

Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer (SWITCH)

Prostatic Neoplasms

Brazil
Floyd & Delores Jones Cancer Institute at Virginia...

Completed

Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Swiss Group for Clinical Cancer Research

Completed

Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery

Esophageal Cancer

Switzerland
National University Hospital, Singapore

Completed

Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle

Solid Tumors

Singapore
Sanofi

Terminated

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Non-Small-Cell Lung Carcinoma

France
Gustave Roussy, Cancer Campus, Grand Paris
LinKinVax

Recruiting

Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer (HPVDCVax)

Head and Neck Carcinoma | Adult Disease

France
GlaxoSmithKline

Completed

An Efficacy Study of Chlorhexidine Mouthwashes

Gingivitis

United Kingdom
Istituto Ortopedico Rizzoli

Recruiting

PRP Versus HA IN OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT

Patellofemoral Osteoarthritis

Italy
Mabwell (Shanghai) Bioscience Co., Ltd.

Recruiting

A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19

Covid19

China
Royan Institute

Completed

Autologous Muscle Derived Stem Cells Transplantation in Urine Incontinency

Stress Incontinency

Iran, Islamic Republic of
Istituto Ortopedico Rizzoli

Recruiting

Treatment of Upper Cluneal Nerve Entrapment Syndrome for Reduction of Low Back Pain

Superior Cluneal Nerve Entrapment

Italy
Shire
Takeda Development Center Americas, Inc.

Completed

A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants

Healthy Volunteers

United States
GE Healthcare

Recruiting

A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

Oncology | Malignant Solid Tumor

Netherlands
Hexin (Suzhou) Pharmaceutical Technology Co., Ltd
Wuhan Union Hospital, China

Completed

A Clinical Study of 68Ga-HX01 Injection for PET Imaging

Healthy | Malignancy

China
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer

Recurrent Non-small Cell Lung Cancer | Squamous Cell Lung Cancer

United States
Sung Yong Oh

Unknown

Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal Carcinoma (DOSE)

Metastatic Cancer | Esophagus Squamous Cell Carcinoma (SCC)

Korea, Republic of
Yonsei University

Withdrawn

An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

NSCLC (Non-Small Cell Lung Cancer)
Cancer Institute and Hospital, Chinese Academy...

Unknown

Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer

Gastric Adenocarcinoma

China
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer (DaeMon-Plus)

Docetaxel, Oxaliplatin and Fluorouracil

China
Cancer Research Network
Hoffmann-La Roche

Completed

A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Prostate Cancer

United States
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer

Breast Cancer

France, Luxembourg
Georgia Center for Oncology Research & Education
Sanofi

Unknown

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer

Breast Neoplasms

United States
Xencor, Inc.

Recruiting

XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer

United States
Fuzhou General Hospital

Terminated

Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC

Nonsmall Cell Lung Cancer

China
Peking University People's Hospital

Completed

Efficacy of Ultrasound-guided Injection of 5% Dextrose for Meralgia Paresthesia

Meralgia Paresthetica

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of TG103 Injection in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

China
Braeburn Pharmaceuticals

Completed

Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence

Opioid Use Disorders

United States
Istituto Ortopedico Rizzoli

Recruiting

Evaluation of the Single Injection of BMAC vs HA in the Treatment of the Ankle Osteoarthritis

Ankle Osteoarthritis

Italy
PromiSight, LLC

Not yet recruiting

Safety and Efficacy of HydroLenz for Vitrectomy-Induced Lens Opacities

Pars Plana Vitrectomy
Simone Spuler, MD

Not yet recruiting

Evaluating Safety and Efficacy of Autologous Gene-edited Muscle Stem Cells (GenPHSats-bASKet)

LGMD
University Hospital, Montpellier
Assistance Publique - Hôpitaux de Paris; Institut National de la Santé Et de... and other collaborators

Active, not recruiting

A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis (ADIPOA-2)

Osteoarthritis

France
LaNova Medicines Development Co., Ltd.
Shanghai Zhongshan Hospital; First Affiliated Hospital of Zhejiang University; Sir Run Run Shaw Hospital and other collaborators

Terminated

Study of LM-102 in Patients With Advance Solid Tumors

Advanced Solid Tumor

China
Mabwell (Shanghai) Bioscience Co., Ltd.
Shanghai Public Health Clinical Center

Completed

A Clinical Study to Evaluate MW33 Injection

Covid19

China
Rutgers University

Completed

Comparison of Therapeutic Effects of Trigger Point Injection and Twin Nerve Block in Chronic Myofascial Pain Patients

Trigger Point Pain, Myofascial | Nerve Block | Myofascial Pain - Dysfunction Syndrome of TMJ
Franklin Pierce University
University of Colorado, Denver

Completed

Epidural Steroid Injection Versus Epidural Steroid Injection and Manual Physical Therapy and Exercise in the Management of Lumbar Spinal Stenosis

Lumbar Spinal Stenosis

United States
University of Washington

Completed

Improving the Concentration of MR Contrast in the Arteries

Contrast Media | Magnetic Resonance Angiography

United States
Green Valley Group of China

Unknown

Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris

Unstable Angina

China
Royan Institute

Completed

Autologous Bone Marrow Derived Stem Cells for Acute Myocardial Infarction

Myocardial Infarction

Iran, Islamic Republic of
University of California, San Francisco
Genzyme, a Sanofi Company

Completed

Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)

Prostate Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United States
Hallym University Medical Center
Jeil Pharmaceutical Co., Ltd.

Unknown

Docetaxel and S-1 for Advanced Esophageal Cancer

Esophageal Neoplasms

Korea, Republic of
OHSU Knight Cancer Institute

Completed

Docetaxel in Treating Patients With Stage IV Prostate Cancer

Pain | Prostate Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction

Gastric Cancer | Esophageal Cancer

United States
Hoffmann-La Roche

Completed

XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer

Breast Cancer

Hungary
BIND Therapeutics

Completed

A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

Squamous Cell Non-small Cell Lung Cancer | KRAS Positive Patients With Non-small Cell Lung Cancer

United States, Russian Federation
BIND Therapeutics

Terminated

A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck (iNSITE2)

Cervical Cancer | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Urothelial Carcinoma

Russian Federation, United States
Indiana University School of Medicine
Aventis Pharmaceuticals

Completed

Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer

Breast Cancer

United States
Wakayama Medical University

Unknown

Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Esophageal Cancer

Japan
Cancer Trials Ireland

Completed

A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients. (TCHL Phase II)

Breast Cancer

Ireland

3

Subscribe